{
  "id": "insilico-medicine-and-qilu-pharmaceutical-strike-near-120m-ai-drug-development-deal",
  "title": "Insilico Medicine and Qilu Pharmaceutical strike near‑$120M AI drug development deal",
  "summary": "Insilico Medicine, a clinical‑stage biotechnology company that uses generative artificial intelligence in drug discovery, and China’s Qilu Pharmaceutical Group have entered a strategic partnership valued at nearly $120 million to co‑develop novel small‑molecule therapies for cardiometabolic diseases, the companies said. The agreement leverages Insilico’s proprietary Pharma.AI platform to design and optimise drug candidates targeting specific metabolic […] The post Insilico Medicine and Qilu Pharmaceutical strike near‑$120M AI drug development deal appeared first on Longevity.Technology.",
  "url": "https://longevity.technology/news/insilico-medicine-and-qilu-pharmaceutical-strike-near-120m-ai-drug-development-deal/",
  "source": "Longevity.Technology",
  "author": null,
  "category": "news",
  "publishedAt": "2026-01-28T17:41:25.000Z",
  "fetchedAt": "2026-02-04T10:49:05.820Z",
  "relevanceScore": 0.2,
  "matchedKeywords": [
    "longevity"
  ],
  "relatedProducts": [],
  "type": "web",
  "savedAt": "2026-02-04T10:49:05.894Z"
}